Alnylam Pharmaceuticals (ALNY) PT Raised to $377 at Wells Fargo
May 1, 2026 7:53 AM
Wells Fargo analyst Derek Archila raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $377.00 (from $376.00) while maintaining a Equal Weight rating.
